ENTX (Entera Bio) E10: $-0.88 (As of Mar. 2026)


ENTX Entera Bio Ltd ENTX
23 GF Score
Price $1.55
! 2 Warning Signs
View Full Analysis

What is Entera Bio E10?

Entera Bio ENTX 23 E10 is $-0.88 as of Mar. 2026. GuruFocus rates ENTX with a GF Score™ of 23/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Entera Bio's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.070. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.88 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-25), Entera Bio's current stock price is $1.55. Entera Bio's E10 for the quarter that ended in Mar. 2026 was $-0.88. Entera Bio's Shiller PE Ratio of today is .


Entera Bio  (NAS:ENTX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Entera Bio E10 Related Terms


Entera Bio E10 Historical Data

* Premium members only.

The historical data trend for Entera Bio's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entera Bio E10 Chart

Entera Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Entera Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.88

ENTX vs IMA, MNOV, ACRV: E10 Comparison

For the Biotechnology subindustry, Entera Bio's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Entera Bio Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entera Bio's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Entera Bio's Shiller PE Ratio falls into.


ENTX
23GF Score
Entera Bio Ltd ENTX
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Entera Bio E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Entera Bio's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.07/330.2130*330.2130
=-0.070

Current CPI (Mar. 2026) = 330.2130.

Entera Bio Quarterly Data

per share eps CPI Adj_EPS
201512 0.000 236.525 0.000
201606 -0.237 241.018 -0.325
201609 -0.203 241.428 -0.278
201612 -0.559 241.432 -0.765
201706 -0.391 244.955 -0.527
201709 -0.521 246.819 -0.697
201712 -0.440 246.524 -0.589
201803 -0.364 249.554 -0.482
201806 -0.110 251.989 -0.144
201809 -0.450 252.439 -0.589
201812 -0.170 251.233 -0.223
201903 -0.260 254.202 -0.338
201906 -0.120 256.143 -0.155
201909 -0.250 256.759 -0.322
201912 -0.260 256.974 -0.334
202003 -0.160 258.115 -0.205
202006 -0.170 257.797 -0.218
202009 -0.090 260.280 -0.114
202012 -0.250 260.474 -0.317
202103 -0.100 264.877 -0.125
202106 -0.100 271.696 -0.122
202109 -0.110 274.310 -0.132
202112 -0.150 278.802 -0.178
202203 -0.130 287.504 -0.149
202206 -0.110 296.311 -0.123
202209 -0.110 296.808 -0.122
202212 -0.100 296.797 -0.111
202303 -0.080 301.836 -0.088
202306 -0.080 305.109 -0.087
202309 -0.080 307.789 -0.086
202312 -0.070 306.746 -0.075
202403 -0.050 312.332 -0.053
202406 -0.060 314.175 -0.063
202409 -0.080 315.301 -0.084
202412 -0.060 315.605 -0.063
202503 -0.060 319.799 -0.062
202506 -0.060 322.561 -0.061
202509 -0.070 324.800 -0.071
202512 -0.070 324.054 -0.071
202603 -0.070 330.213 -0.070

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.88 mean?
Entera Bio (ENTX) has a E10 of $-0.88 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Entera Bio and its competitors.
Is Entera Bio's E10 too high?
Entera Bio's current E10 is $-0.88. Overall, Entera Bio has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Entera Bio's E10 compare to IMA and MNOV?
Entera Bio's E10 of $-0.88 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Entera Bio and its competitors. Entera Bio's current E10 is $-0.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entera Bio stock overvalued right now?
Entera Bio (ENTX) has a current E10 of $-0.88. The current E10 is $-0.88. Entera Bio's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Entera Bio (ENTX), the current E10 is $-0.88 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entera Bio Business Description

Other Exchanges 5DT:Germany
Address Kiryat Hadassah, Minrav Building - Fifth Floor, Hadassah Bio Park, Jerusalem, ISR, 9112002
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.
23GF Score

Get the complete analysis for ENTX

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.55
Price